Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03581552 · ClinicalTrials.gov registry record
Effects of Aromatase Inhibitor Therapy on Muscle Function
A clinical trial of Breast Cancer and Breast Cancer Female, sponsored by Tarah J Ballinger, MD.
- Completed
- Registry status
- 16
- Enrollment target
- 1
- Study location
NCT03581552: Completed study of Breast Cancer and Breast Cancer Female, sponsored by Tarah J Ballinger, MD.
NCT03581552 is a study of Breast Cancer and Breast Cancer Female that has completed, run by Tarah J Ballinger, MD. The registered enrollment target is 16 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03581552, a study of Breast Cancer and Breast Cancer Female, has completed, sponsored by Tarah J Ballinger, MD.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study designed to examine changes in muscle function after Aromatase Inhibitor (AI) therapy, at both the molecular and clinical level.
Conditions Studied
Study Locations (1)
Indiana
- IU Simon Cancer Center - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-07-26 |
| Est. Completion | 2020-02-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03581552
The ClinicalTrials.gov registry entry for NCT03581552 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Tarah J Ballinger, MD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT03581552 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT03581552 about?
NCT03581552 is a clinical study titled "Effects of Aromatase Inhibitor Therapy on Muscle Function". This is a pilot study designed to examine changes in muscle function after Aromatase Inhibitor (AI) therapy, at both the molecular and clinical level.
What is the current status of trial NCT03581552?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2018-07-26. Estimated completion is 2020-02-07.
What conditions does trial NCT03581552 study?
This clinical trial studies the following conditions: Breast Cancer, Breast Cancer Female.
Who is sponsoring clinical trial NCT03581552?
This trial is sponsored by Tarah J Ballinger, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03581552 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.